Coping with hypoxemia: Could erythropoietin (EPO) be an adjuvant treatment of COVID-19?

A very recent epidemiological study provides preliminary evidence that living in habitats located at 2500 m above sea level (masl) might protect from the development of severe respiratory symptoms following infection with the novel SARS-CoV-2 virus. This epidemiological finding raises the question o...

Descripción completa

Detalles Bibliográficos
Autores principales: Soliz, Jorge, Schneider-Gasser, Edith M., Arias-Reyes, Christian, Aliaga-Raduan, Fernanda, Poma-Machicao, Liliana, Zubieta-Calleja, Gustavo, Furuya, Werner I., Trevizan-Baú, Pedro, Dhingra, Rishi R., Dutschmann, Mathias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275159/
https://www.ncbi.nlm.nih.gov/pubmed/32522574
http://dx.doi.org/10.1016/j.resp.2020.103476

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275159/
https://www.ncbi.nlm.nih.gov/pubmed/32522574
http://dx.doi.org/10.1016/j.resp.2020.103476

Ejemplares similares